Empirical Asset Management’s Charles River Laboratories CRL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$260K Hold
1,508
0.07% 318
2025
Q4
$301K Sell
1,508
-5
-0.3% -$907 0.08% 263
2025
Q3
$237K Buy
1,513
+7
+0.5% +$1.11K 0.07% 325
2025
Q2
$229K Hold
1,506
0.07% 287
2025
Q1
$227K Buy
1,506
+86
+6% +$14.4K 0.08% 288
2024
Q4
$262K Sell
1,420
-199
-12% -$38.3K 0.09% 251
2024
Q3
$319K Buy
1,619
+23
+1% +$4.78K 0.11% 221
2024
Q2
$330K Buy
1,596
+97
+6% +$22K 0.12% 227
2024
Q1
$406K Buy
+1,499
New +$358K 0.2% 142

Other funds holding CRL

Empirical Asset Management's CRL Position: Q1 2026 in Review

Empirical Asset Management held its Charles River Laboratories (CRL) position steady in Q1 2026 at 1,508 shares worth $260K. The position accounts for 0.07% of the portfolio, ranked #318.

Empirical Asset Management first reported a position in CRL in Q1 2024 and has held it in 9 quarters since. The position peaked at $406K in Q1 2024. 557 funds tracked by Wall St. Rank hold CRL as of Q1 2026.

  • Empirical Asset Management held 1,508 shares of Charles River Laboratories worth $260K as of Q1 2026.
  • Empirical Asset Management left its Charles River Laboratories share count unchanged in Q1 2026.
  • Charles River Laboratories made up 0.07% of Empirical Asset Management's portfolio in Q1 2026, its #318 holding.
  • Empirical Asset Management first reported a position in Charles River Laboratories in Q1 2024 and has held it in 9 quarters since.
  • Empirical Asset Management's Charles River Laboratories position peaked at $406K in Q1 2024.
  • 557 funds tracked by Wall St. Rank held Charles River Laboratories as of Q1 2026.

Based on Empirical Asset Management's 13F filing for Q1 2026, filed 11 May 2026.